Village Farms International (VFF) 10-Q 9 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 09, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Trading Symbol	VFF
Entity Registrant Name	VILLAGE FARMS INTERNATIONAL, INC.
Entity Central Index Key	0001584549
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Security Exchange Name	NASDAQ
Entity Address, Country	CA
Title of 12(b) Security	Common Shares, without par value
Entity File Number	001-38783
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	98-1007671
Entity Address, State or Province	BC
Entity Address, Address Line One	4700-80th Street
Entity Address, City or Town	Delta
Entity Address, Postal Zip Code	V4K 3N3
City Area Code	604
Local Phone Number	940-6012
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		85,705,649

Condensed Consolidated Interim

Condensed Consolidated Interim Statements of Financial Position - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 79,199	$ 21,640
Restricted cash	5,251	4,039
Trade receivables	34,183	23,222
Inventories	53,934	46,599
Other receivables	957	145
Income tax receivable	21	18
Prepaid expenses and deposits	9,708	6,145
Total current assets	183,253	101,808
Non-current assets
Property, plant and equipment	196,271	187,020
Investment in minority interests	2,334	1,226
Note receivable - joint venture	3,385	3,545
Goodwill	93,356	24,027
Intangibles	16,833	17,311
Deferred tax asset	16,575	13,312
Right-of-use assets	8,019	3,832
Other assets	2,646	1,950
Total assets	522,672	354,031
Current liabilities
Line of credit		2,000
Trade payables	16,032	15,064
Current maturities of long-term debt	10,342	10,166
Note payable		15,314
Accrued sales taxes	2,107
Accrued loyalty program	2,363
Accrued liabilities	22,328	22,438
Lease liabilities - current	1,056	1,134
Income tax payable	2,270	4,523
Other current liabilities	2,524	1,641
Total current liabilities	59,022	72,280
Non-current liabilities
Long-term debt	52,723	53,913
Deferred tax liability	19,002	18,059
Lease liabilities - non-current	7,044	2,863
Other liabilities	1,904	1,633
Total liabilities	139,695	148,748
Commitments and contingencies (note 18)
SHAREHOLDERS’ EQUITY
Common stock, no par value per share - unlimited shares authorized; 86,241,701 shares issued and 85,705,649 shares outstanding at September 30, 2021, and 66,911,811 shares issued and outstanding at December 31, 2020.	344,269	145,668
Additional paid in capital	7,541	17,502
Accumulated other comprehensive income	6,463	6,255
Retained earnings	24,704	35,858
Total shareholders’ equity	382,977	205,283
Total liabilities and shareholders’ equity	$ 522,672	$ 354,031

Condensed Consolidated Interi_2

Condensed Consolidated Interim Statements of Financial Position (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Assets [Abstract]
Common stock, no par value
Common Stock, Shares, Issued	86,241,701	66,911,811
Common Stock, Shares, Outstanding	85,705,649	66,911,811

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Sales	$ 72,442	$ 43,037	$ 195,212	$ 122,722
Cost of sales	(54,693)	(37,418)	(169,891)	(112,809)
Gross margin	17,749	5,619	25,321	9,913
Selling, general and administrative expenses	(13,132)	(4,942)	(30,249)	(12,676)
Share-based compensation	(1,820)	(472)	(5,705)	(1,329)
Interest expense	(620)	(299)	(1,959)	(1,273)
Interest income	50	101	99	577
Foreign exchange loss	(324)	(484)	(635)	(880)
Gain on settlement agreement				4,681
Other (expense) income	(119)	27	(354)	92
Loss on disposal of assets			(40)	(6)
Income (loss) before taxes and earnings of unconsolidated entities	1,784	(450)	(13,522)	(901)
(Provision for) recovery of income taxes	(1,077)	(336)	2,543	607
Income (loss) from consolidated entities after income taxes	707	(786)	(10,979)	(294)
Equity earnings (losses) from unconsolidated entities	38	1,306	(175)	4,885
Net income (loss)	$ 745	$ 520	$ (11,154)	$ 4,591
Basic income(loss) per share	$ 0.01	$ 0.01	$ (0.14)	$ 0.08
Diluted income (loss) per share	$ 0.01	$ 0.01	$ (0.14)	$ 0.08
Weighted average number of common shares used in the computation of net income (loss) per share (in thousands):
Basic	84,823	58,536	80,671	55,946
Diluted	86,910	60,440	80,671	57,778
Net income (loss)	$ 745	$ 520	$ (11,154)	$ 4,591
Other comprehensive (loss) income:
Foreign currency translation adjustment	(3,869)	31	208	(41)
Comprehensive (loss) income	$ (3,124)	$ 551	$ (10,946)	$ 4,550

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]
Beginning Balance at Dec. 31, 2019	$ 126,459	$ 98,333	$ 4,351	$ (475)	$ 24,250
Beggining Balance (in shares) at Dec. 31, 2019		52,657,000
Shares issued in public offering, net of issuance costs	42,569	$ 42,569
Shares issued in pubic offering, net of issuance costs (in shares)		12,990,000
Warrants issued in public offering	11,369		11,369
Shares issued on exercise of stock options	251	$ 408	(157)
Shares issued on exercise of stock options (in shares)		313,000
Share-based compensation	1,329		1,329
Cumulative translation adjustment	(41)			(41)
Net income (loss)	4,591				4,591
Ending Balance at Sep. 30, 2020	186,527	$ 141,310	16,892	(516)	28,841
Ending Balance (in shares) at Sep. 30, 2020		65,960,000
Beginning Balance at Dec. 31, 2019	126,459	$ 98,333	4,351	(475)	24,250
Beggining Balance (in shares) at Dec. 31, 2019		52,657,000
Ending Balance at Dec. 31, 2020	205,283	$ 145,668	17,502	6,255	35,858
Ending Balance (in shares) at Dec. 31, 2020		66,912,000
Beginning Balance at Jun. 30, 2020	138,731	$ 105,829	5,128	(547)	28,321
Beggining Balance (in shares) at Jun. 30, 2020		56,403,000
Shares issued in public offering, net of issuance costs	35,275	$ 35,275
Shares issued in pubic offering, net of issuance costs (in shares)		9,396,000
Warrants issued in public offering	11,369		11,369
Shares issued on exercise of stock options	129	$ 206	(77)
Shares issued on exercise of stock options (in shares)		161,000
Share-based compensation	472		472
Cumulative translation adjustment	31			31
Net income (loss)	520				520
Ending Balance at Sep. 30, 2020	186,527	$ 141,310	16,892	(516)	28,841
Ending Balance (in shares) at Sep. 30, 2020		65,960,000
Beginning Balance at Dec. 31, 2020	205,283	$ 145,668	17,502	6,255	35,858
Beggining Balance (in shares) at Dec. 31, 2020		66,912,000
Shares issued in public offering, net of issuance costs	127,489	$ 127,489
Shares issued in pubic offering, net of issuance costs (in shares)		10,887,000
Shares issued in acquisition	41,752	$ 41,752
Shares issued in acquisition (in shares)		4,707,000
Shares issued on exercise of warrants	18,495	$ 29,050	(10,555)
Shares issued on exercise of warrants (in shares)		3,188,000
Shares issued on exercise of stock options	199	$ 310	(111)
Shares issued on exercise of stock options (in shares)		177,000
Share re-purchases	$ (5,000)		(5,000)
Share re-purchases (in shares)	(536,052)	(535,000)
Share-based compensation	$ 5,705		5,705
Share-based compensation (in shares)		370,000
Cumulative translation adjustment	208			208
Net income (loss)	(11,154)				(11,154)
Ending Balance at Sep. 30, 2021	382,977	$ 344,269	7,541	6,463	24,704
Ending Balance (in shares) at Sep. 30, 2021		85,706,000
Beginning Balance at Jun. 30, 2021	343,536	$ 302,497	6,748	10,332	23,959
Beggining Balance (in shares) at Jun. 30, 2021		80,964,000
Shares issued in acquisition	41,752	$ 41,752
Shares issued in acquisition (in shares)		4,707,000
Shares issued on exercise of stock options	13	$ 20	(7)
Shares issued on exercise of stock options (in shares)		15,000
Share re-purchases	(1,020)		(1,020)
Share re-purchases (in shares)		(107,000)
Share-based compensation	1,820		1,820
Share-based compensation (in shares)		127,000
Cumulative translation adjustment	(3,869)			(3,869)
Net income (loss)	745				745
Ending Balance at Sep. 30, 2021	$ 382,977	$ 344,269	$ 7,541	$ 6,463	$ 24,704
Ending Balance (in shares) at Sep. 30, 2021		85,706,000

Condensed Consolidated Interi_5

Condensed Consolidated Interim Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash flows (used in) provided by operating activities:
Net income (loss)	$ 745	$ 520	$ (11,154)	$ 4,591
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization			9,364	4,540
Amortization of deferred charges			234	57
Share of loss (income) from joint ventures	(38)	(1,306)	175	(4,885)
Bad debt expense			(19)
Interest expense	620	299	1,959	1,273
Interest income	(50)	(101)	(99)	(577)
Interest paid on long-term debt			(2,926)	(1,318)
Unrealized foreign exchange gain/loss			19
Gain on settlement agreement				(4,681)
Loss on disposal of assets			40	6
Non-cash lease expense			(376)	(935)
Interest paid on finance lease		(1)	(1)	(3)
Share-based compensation			5,705	1,329
Deferred income taxes			(3,196)	(321)
Changes in non-cash working capital items			(20,831)	4,938
Net cash (used in) provided by operating activities			(21,106)	4,014
Cash flows used in investing activities:
Purchases of property, plant and equipment			(15,131)	(1,076)
Advances to joint ventures			(15)	(133)
Acquisitions, net			(25,944)	(11,713)
Investment in minority interests			(1,109)	(1,226)
Net cash used in investing activities			(42,199)	(14,148)
Cash flows provided by financing activities:
Proceeds from borrowings			4,147	3,000
Repayments on borrowings			(7,410)	(4,326)
Proceeds from issuance of common stock and warrants			135,000	46,388
Issuance costs			(7,511)	(3,819)
Proceeds from exercise of stock options			199	251
Proceeds from exercise of warrants			18,495	11,369
Share re-purchases			(5,000)
Payments on capital lease obligations			(537)	(51)
Payment of note payable related to acquisition of Pure Sunfarms			(15,498)
Net cash provided by financing activities			121,885	52,812
Effect of exchange rate changes on cash and cash equivalents			191	(1)
Net increase in cash and cash equivalents			58,771	42,677
Cash and cash equivalents, beginning of period			25,679	11,989	$ 11,989
Cash and cash equivalents, end of period	$ 84,450	$ 54,666	84,450	$ 54,666	$ 25,679
Supplemental disclosure of non-cash activities:
Shares issued for acquisition			$ 41,752

Nature of Operations

Nature of Operations	9 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Nature of Operations	1 Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”, “we”, “us”, or “our”) is incorporated under the Canada Business Corporations Act. VFF’s principal operating subsidiaries as of September 30, 2021 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), VF Clean Energy, Inc. (“VFCE”), Pure Sunfarms Corp. (“Pure Sunfarms” or “PSF”), and Balanced Health Botanicals, LLC (“Balanced Health” or “BHB”). The address of the registered office of VFF is 4700-80th Street, Delta, British Columbia, Canada, V4K 3N3. VFF also owns a 65% equity interest in Village Fields Hemp USA LLC (“VF Hemp”), which is recorded as an equity investment (note 10). The Company’s shares are listed on both the Toronto Stock Exchange and the Nasdaq Capital Market (“Nasdaq”), in each case, under the symbol “VFF”. The Company owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers and cucumbers. The Company, through Pure Sunfarms, is a vertically-integrated licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Company, through BHB, develops and sells high-quality, cannabidiol (“CBD”) based products including ingestible, edible and topical applications. The Company, through VFCE, owns and operates a

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	2 The accompanying unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2021 have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for fair presentation have been included. Operating results for the three and nine months ended September 30, 2021 are subject to seasonal variations and accordingly are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. For further information, refer to the Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal years ended December 31, 2020 and 2019.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2021
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
New Accounting Pronouncements	3 In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. The Company has a line of credit that incorporates LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on the Company’s business or on the overall financial markets. The Company has not adopted any of the optional expedients or exceptions through September 30, 2021 but will continue to evaluate the possible adoption of any such expedients or exceptions.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventories	4 Inventories consisted of the following: Classification September 30, 2021 December 31, 2020 Cannabis: Raw materials $ 9,340 $ 13,168 Work-in-process 3,591 2,971 Finished goods 18,003 13,722 Packaging 5,205 2,360 Produce and Energy: Crop inventory 15,669 13,441 Purchased produce inventory 1,997 810 Spare parts inventory 129 127 Inventory $ 53,934 $ 46,599

Property Plant And Equipment

Property Plant And Equipment	9 Months Ended
	Sep. 30, 2021
Property Plant And Equipment [Abstract]
Property Plant And Equipment	5 Property, plant and equipment consisted of the following: Classification September 30, 2021 December 31, 2020 Land $ 13,922 $ 13,895 Leasehold and land improvements 5,118 4,154 Buildings 151,989 142,060 Machinery and equipment 77,568 69,390 Construction in progress 49,955 49,512 Less: Accumulated depreciation (102,281 ) (91,991 ) Property, plant and equipment, net $ 196,271 $ 187,020

Intangibles

Intangibles	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Intangibles	6 INTANGIBLES Intangibles consisted of the following: Classification September 30, 2021 December 31, 2020 Licenses $ 12,824 $ 12,870 Branding 3,697 3,688 Computer Software 947 945 Other 144 — Less: Accumulated amortization (779 ) (192 ) Intangibles, net $ 16,833 $ 17,311 The expected future amortization expense for definite-lived intangible assets as of September 30, 2021 was as follows: Fiscal period Remainder of 2021 $ 197 2022 786 2023 780 2024 780 2025 688 Thereafter 9,761 Intangibles, net $ 12,992

Leases

Leases	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Leases	7 The Company leases a parcel of land in Marfa, Texas where one of its greenhouses resides, as well as two distribution centers located in Fort Worth, Texas and Surrey, British Columbia. The Company leases production-related equipment at its greenhouses in Texas and British Columbia. The Company also leases an office building located in Lake Mary, Florida for its corporate headquarters, and office and manufacturing space in Denver, Colorado for BHB’s headquarters and operations. The components of lease related expenses are as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Operating lease expense (a) $ 757 $ 533 $ 2,020 $ 1,649 Finance lease expense: Amortization of right-of-use assets $ 4 $ 12 $ 21 $ 51 Interest on lease liabilities — 1 1 3 Total finance lease expense $ 4 $ 13 $ 22 $ 54 (a) Includes short-term lease costs of $194 and $275 for the three months ended September 30, 2021 and 2020, respectively, and $497 and $315 for the nine months ended September 30, 2021 and 2020, respectively. Cash paid for amounts included in the measurement of lease liabilities: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Operating cash flows from operating leases $ 122 $ 308 $ 376 $ 935 Operating cash flows from finance leases $ - $ 1 $ 1 $ 3 Finance cash flows from finance leases $ 227 $ 12 $ 537 $ 51 September 30, 2021 Weighted average remaining lease term: Operating leases 6.5 Finance leases 0.9 Weighted average discount rate: Operating leases 8.43% Finance leases 6.25% Maturities of lease liabilities are as follows: Operating leases Finance leases Remainder of 2021 $ 583 $ 5 2022 2,137 9 2023 1,900 — 2024 1,386 — 2025 1,145 — Thereafter 4,348 — Undiscounted lease cash flow commitments 11,499 14 Reconciling impact from discounting (3,411 ) (2 ) Lease liabilities on consolidated statement of financial position as of September 30, 2021 $ 8,088 $ 12

PURE SUNFARMS ACQUISITION

PURE SUNFARMS ACQUISITION	9 Months Ended
	Sep. 30, 2021
Business Combinations [Abstract]
Pure Sunfarms Acquisitions	8 On November 2, 2020, Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”), acquiring 36,958,500 common shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100%. The shares were acquired for a total purchase price of C$79.9 million (US$60.0 million), satisfied through an initial C$60.0 million (US$45.0 million) cash payment and a C$19.9 million (US$15.0 million) secured promissory note that was payable to Emerald, which promissory note was repaid in full on February 8, 2021. The acquisition was a business combination and has been accounted for in accordance with the measurement and recognition provisions of Accounting Standards Codification (“ASC”) Topic 805, Business Combinations ) The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, in accordance with ASC Topic 323, Equity Method and Joint Ventures On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5% of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$6.5 million (US$4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Condensed Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the nine months ended September 30, 2020. Summarized financial information of Pure Sunfarms: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales $ 27,393 $ 17,048 $ 69,614 $ 39,571 Cost of sales* (14,244 ) (11,154 ) (44,433 ) (23,678 ) Gross Margin 13,149 5,894 25,181 15,893 Selling, general and administrative expenses (5,510 ) (2,447 ) (15,131 ) (6,731 ) Income from operations 7,639 3,447 10,050 9,162 Interest expense, net (563 ) (386 ) (1,362 ) (734 ) Foreign exchange (loss) gain 105 (56 ) (131 ) (207 ) Loss on disposal — — (40 ) — Other income, net** 131 (131 ) (188 ) 4,202 Income before taxes 7,312 2,874 8,329 12,423 Provision for income taxes (2,024 ) (417 ) (2,654 ) (3,012 ) Net income $ 5,288 $ 2,457 $ 5,675 $ 9,411 * Included in cost of sales for the three months ended September 30, 2021 and 2020 is ** Includes gain recognized on settlement of net liabilities of $4,348.

BALANCED HEALTH BOTANICALS ACQU

BALANCED HEALTH BOTANICALS ACQUISITION	9 Months Ended
	Sep. 30, 2021
Pure Sunfarms Acquisitions	8 On November 2, 2020, Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”), acquiring 36,958,500 common shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100%. The shares were acquired for a total purchase price of C$79.9 million (US$60.0 million), satisfied through an initial C$60.0 million (US$45.0 million) cash payment and a C$19.9 million (US$15.0 million) secured promissory note that was payable to Emerald, which promissory note was repaid in full on February 8, 2021. The acquisition was a business combination and has been accounted for in accordance with the measurement and recognition provisions of Accounting Standards Codification (“ASC”) Topic 805, Business Combinations ) The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, in accordance with ASC Topic 323, Equity Method and Joint Ventures On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5% of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$6.5 million (US$4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Condensed Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the nine months ended September 30, 2020. Summarized financial information of Pure Sunfarms: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales $ 27,393 $ 17,048 $ 69,614 $ 39,571 Cost of sales* (14,244 ) (11,154 ) (44,433 ) (23,678 ) Gross Margin 13,149 5,894 25,181 15,893 Selling, general and administrative expenses (5,510 ) (2,447 ) (15,131 ) (6,731 ) Income from operations 7,639 3,447 10,050 9,162 Interest expense, net (563 ) (386 ) (1,362 ) (734 ) Foreign exchange (loss) gain 105 (56 ) (131 ) (207 ) Loss on disposal — — (40 ) — Other income, net** 131 (131 ) (188 ) 4,202 Income before taxes 7,312 2,874 8,329 12,423 Provision for income taxes (2,024 ) (417 ) (2,654 ) (3,012 ) Net income $ 5,288 $ 2,457 $ 5,675 $ 9,411 * Included in cost of sales for the three months ended September 30, 2021 and 2020 is ** Includes gain recognized on settlement of net liabilities of $4,348.
Balanced Health Botanicals
Pure Sunfarms Acquisitions	9 BALANCED HEALTH BOTANICALS ACQUISITION On August 16, 2021, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”), by and among Village Farms, Balanced Health and the other parties thereto, including the members of Balanced Health (collectively, the “Sellers”). The Purchase Agreement provided for the acquisition of a 100% interest in Balanced Health (the “Balanced Health Acquisition”), for a total purchase price comprised of a cash purchase price of approximately $30 million, and an aggregate of 4,707,113 of our common shares, with a fair value of approximately $42 million, issued to the Sellers on In connection with the Balanced Health Acquisition, each of the Sellers entered into a lock-up agreement with us, pursuant to which each such Seller has agreed not to resell the Village Farms common shares received as consideration in the Balanced Health Acquisition until such common shares cease to be “Restricted Shares” (as defined in the Purchase Agreement) (“Restricted Shares”). Under the terms of the Purchase Agreement and the lock-up agreements, such common shares cease to be Restricted Shares, as follows: (i) with respect to one-fourth ( 1/4 1/4 1/4 1/4 The acquisition meets the definition of a business combination and is being accounted for in accordance with the measurement and recognition provisions of ASC Topic 805. ASC Topic 805 requires that the purchase consideration be allocated to the assets acquired and liabilities assumed in a business combination based upon their estimated fair values at the date of acquisition. As of the date of this Quarterly Report on Form 10-Q, Village Farms has not completed the detailed valuation study necessary to arrive at the required final estimates of the fair value of Balanced Health’s tangible and intangible assets acquired and liabilities assumed and the related calculation of goodwill. As a result, the fair value of assets acquired, Based upon preliminary estimates, the Company identified goodwill of $69,269. This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Balanced Health and the estimated fair value of all assets and liabilities acquired. The Company expects to recognize intangible assets but is still in the process of identifying and valuing the assets. The Company expects the accounting for the business combination to be complete by December 31, 2021. The following table shows the preliminary allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 30,000 Village Farms common shares issued 4,707,113 $ 8.87 41,752 Working capital adjustment $ 192 Total fair value of consideration $ 71,944 August 16, 2021 ASSETS Cash and cash equivalents $ 4,056 Trade and other receivables, net 1,030 Inventories 1,796 Prepaid expenses and deposits 667 Property, plant and equipment 1,900 Right-of-use asset 5,099 Goodwill 69,269 Intangibles 144 Other assets 362 Total assets 84,323 LIABILITIES Trade payables 672 Accrued liabilities 5,974 Deferred revenue 192 Lease liability 5,541 Total liabilities 12,379 Net assets acquired 71,944 Pro Forma Financial Information (unaudited) The following unaudited pro forma financial information presents the Company’s consolidated results assuming the Balanced Health Acquisition occurred on January 1, 2020. Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales $ 75,872 $ 51,518 $ 214,060 $ 150,283 Net income $ 2,376 $ (134) $ (6,816) $ 250

Investment In Joint Ventures An

Investment In Joint Ventures And Minority Interests	9 Months Ended
	Sep. 30, 2021
Equity Method Investments And Joint Ventures [Abstract]
Investment in Joint Ventures and Minority Interests	10 INVESTMENTS IN JOINT VENTURES AND MINORITY INTERESTS Village Fields Hemp USA LLC The Company’s share of the joint venture consisted of the following: Balance, January 1, 2020 $ — Share of net loss (552 ) Losses applied against joint venture note receivable 552 Balance, December 31, 2020 $ — Balance, January 1, 2021 $ — Share of net loss (175 ) Losses applied against joint venture note receivable 175 Balance, September 30, 2021 $ — Summarized financial information of VF Hemp: September 30, 2021 December 31, 2020 Current assets Inventory $ 4,035 $ 4,035 Other current assets 189 302 Non-current assets 857 937 Current liabilities (1,529 ) (1,472 ) Non-current liabilities (13,715 ) (13,697 ) Net assets $ (10,163 ) $ (9,895 ) Reconciliation of net assets: Accumulated retained earnings $ (9,905 ) $ (3,791 ) Net loss (268 ) (6,114 ) Contributions from joint venture partners 10 10 Net assets $ (10,163 ) $ (9,895 ) During the nine months ended September 30, 2021, the Company exercised a portion of its options and purchased additional shares in Australia-based Altum International Pty Ltd (“Altum”), bringing the Company’s total investment in Altum to 11.9%. In September 2021, the Company entered into an option agreement whereby the Company received the irrevocable right to acquire an 80% ownership interest (the “Option Agreement”) in Netherlands-based Leli Holland B.V. (“Leli”) upon payment of EUR50,000 (the “Option”). The Option Agreement allows the Company to acquire 80% of Leli’s shares for EUR3,950,000, of which EUR950,000 is due and payable to Leli’s shareholders upon the exercise of the Option and the remainder due in three equal installments subject to the achievement of certain project development milestones. The option is exercisable at the sole discretion of the Company for a period of 5 years. Leli is one of ten applicants selected to receive a license (subject to customary government approval) to legally cultivate and distribute cannabis to retailers when the Dutch government implements its Experiment to Investigate Closed Cannabis Supply Chains (“Dutch Supply Chain Experiment”). The Dutch Supply Chain Experiment is specified by the Dutch government to be approximately 65,000 kilograms of dried flower annually from the ten approved producers during the first year. Leli and Village Farms plan to construct two indoor CEA production facilities, leveraging Leli’s track record managing complex regulatory and approval procedures in the Netherlands at both the federal and local levels and Village Farms’ three-plus decades as a vertically integrated CEA grower, as well as its extensive experience in cultivation, product development and commercialization in the Canadian legal recreational cannabis market. As the majority owner of Leli, the Company will be responsible for the development of the project and product commercialization throughout the fully vertically integrated business model.

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	11 September 30, 2021 December 31, 2020 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $164 and accrued interest at a rate of 3.691%; matures April 1, 2025 $ 27,214 $ 28,690 Term Loan - VFCE: CA$3.0M - non-revolving fixed rate loan with fixed interest rate of 4.98%; matures June 2023 595 797 Advance on term loan - VFCE: CA$250 - repayable in monthly installments of principle plus interest rate of CA$ prime rate plus 200 basis points - paid in full June 2021 — 69 Term Loan - Pure Sunfarms - CA$19.0M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount, interest rate of 4.95%; matures February, 2024 12,177 13,385 Term loan - Pure Sunfarms - CA$25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount starting June 30, 2021, interest rate of 4.95%; matures February 2024 18,169 16,535 BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75%, matures December 31, 2031 4,910 4,905 Unamortized deferred financing fees — (302 ) Total $ 63,065 $ 64,079 The Company’s line of credit (“Operating Loan”) had no amount drawn on the facility as of September 30, 2021, while there was $2,000 drawn as of December 31, 2020. The carrying value of the assets and securities pledged as collateral for the FCC Loan as of September 30, 2021 and December 31, 2020 was $223,788 and $86,664, respectively. The carrying value of the assets pledged as collateral for the Operating Loan as of September 30, 2021 and December 31, 2020 was $28,414 and $23,443, respectively. The Company was in compliance with all of its credit facility covenants as of September 30, 2021. On March 15, 2021, Pure Sunfarms entered into the Third Amended and Restated Credit Agreement (the “Third Amended and Restated PSF Credit Agreement) with Farm Credit Canada and two Canadian chartered banks, which extended the maturity date of each of the PSF Revolving Line of Credit, PSF Non-Revolving Facility and the PSF Term Loan through February 7, 2024, included an unlimited guarantee from Village Farms and changed certain financial covenants. The Third Amended and Restated PSF Credit Agreement amended and updated the previous three loan facilities. The PSF Revolving Line of Credit had no balance as of September 30, 2021 and December 31, 2020, respectively. The weighted average annual interest rate on short-term borrowings as of September 30, 2021 and December 31, 2020 was 5.30% Accrued interest payable on the C redit F acilities and loans as of September 30, 2021 and December 31, 2020 was $34 and $189 , respectively, and these amounts are included in accrued liabilities in the Condensed I nterim S tatements of F inancial P osition. The aggregate annual maturities of long-term debt for the remainder of 2021 and thereafter are as follows: Remainder of 2021 $ 1,920 2022 7,884 2023 7,534 2024 26,052 2025 22,278 Thereafter 3,491 Total $ 69,159

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2021
Investments All Other Investments [Abstract]
Financial Instruments	12 The Company’s financial instruments

Related Party Transactions And

Related Party Transactions And Balances	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transaction And Balances	13 On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp. The Grid Loan has a maturity date of March 25, 2022 and bears simple interest at the rate of 8% per annum, calculated monthly. As of September 30, 2021 and December 31, 2020, the Grid Loan balance was $3,385 One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $96 and $84 in salary and benefits during the nine months ended September 30, 2021 and 2020, respectively. During 2020, the Company advanced a loan of $249 to an employee in connection with a relocation at the request of the Company. During the nine months ended September 30, 2021, the employee repaid $124 of the outstanding loan balance. On July 7, 2021, the Company forgave the remaining balance.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	14 A provision for income taxes is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the nine months ended September 30, 2021 and September 30, 2020 was 22% and 24%, respectively. For the three months ended September 30, 2021 and 2020, there was a provision of income taxes of $1,077 and $336, respectively. There was a recovery of income taxes of $2,543 and 607 for the nine months ended September 30, 2021 and 2020, respectively.

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment and Geographic Information	1 5 Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, manages the business, makes operating decisions and assesses performance. Management has determined that the Company operates in four segments. The Company’s four segments include Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The Produce segment produces, markets and sells premium quality tomatoes, bell peppers and cucumbers. The Cannabis-Canada segment produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Cannabis-U.S segment develops and sells high-quality, CBD-based health and wellness products including ingestible, edible and topical applications. The Energy business produces power that it sells pursuant to a long-term contract to its one customer. The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales Produce $ 41,035 $ 42,939 $ 121,441 $ 122,356 Cannabis - Canada 27,393 — 69,614 — Cannabis - United States 3,838 — 3,838 — Energy 176 98 319 366 $ 72,442 $ 43,037 $ 195,212 $ 122,722 Gross margin Produce $ 2,052 $ 5,828 $ (1,045 ) $ 10,494 Cannabis - Canada 13,149 — 25,181 — Cannabis - United States 2,607 — 2,607 — Energy (59 ) (209 ) (1,422 ) (581 ) $ 17,749 $ 5,619 $ 25,321 $ 9,913

Income (Loss) Per Share

Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Income (Loss) Per Share	16 Basic and diluted net income (loss) per common share is calculated as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Numerator: Net income (loss) $ 745 $ 520 $ (11,154 ) $ 4,591 Denominator: Weighted average number of common shares - basic 84,823 58,536 80,671 55,946 Effect of dilutive securities- share-based employee options and awards 2,087 1,904 — 1,832 Weighted average number of common shares - diluted 86,910 60,440 80,671 57,778 Antidilutive options and awards 999 865 389 865 Net income (loss) per ordinary share: Basic $ 0.01 $ 0.01 $ (0.14 ) $ 0.08 Diluted $ 0.01 $ 0.01 $ (0.14 ) $ 0.08

Shareholders' Equity and Share

Shareholders' Equity and Share Based Compensation	9 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Shareholders' Equity and Share Based Compensation	1 7 On August 16, 2021, the Company acquired Balanced Health. Under the terms of the Acquisition Agreement, 4,707,113 common shares of the Company were issued to the owners of Balanced Health as part of the consideration. On May 21, 2021, the Company announced that the Toronto Stock Exchange (“TSX”) had accepted a notice filed by the Company of its intention to make a normal course issuer bid (“NCIB”). The NCIB notice provides that Village Farms may, during the 12-month period commencing On September 10, 2020, the Company sold 9,396,226 units through a registered direct offering. Each unit that was sold consisted of one common share of the Company and one-half (0.5) of a warrant to purchase a common share of the Company at a price of $5.80. On March 10, 2021, the warrants became exercisable and will expire on September 10, 2025. As of September 30, 2021, 3,188,680 of the warrants have been exercised. Share-based compensation expense for the three and nine months ended September 30, 2021 was $1,820 and $5,705, respectively, and $472 and $1,329 for the three and nine months ended September 30, 2020, respectively. Stock option activity for the nine months ended September 30, 2021 was as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2021 3,067,322 C$ 6.91 6.82 $ 20,051 Granted 220,300 C$ 12.17 9.49 $ — Exercised (177,000 ) C$ 1.34 1.14 $ — Outstanding at September 30, 2021 3,110,622 C$ 7.60 6.36 $ 13,035 Exercisable at September 30, 2021 2,069,329 C$ 6.19 5.16 $ 11,305 Performance-based shares activity for the nine months ended September 30, 2021 was as follows: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Outstanding at January 1, 2021 869,000 C$ 7.51 Received (370,000 ) C$ 6.94 Outstanding at September 30, 2021 499,000 C$ 7.93 Exercisable at September 30, 2021 114,000 C$ 7.97

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	18 In the normal course of business, the Company and its subsidiaries may become defendants in certain employment claims and other litigation. The Company records a liability when it is probable that a loss has been incurred and the amount can be reasonably estimated. The Company is not involved in any legal proceedings other than routine litigation arising in the normal course of business, none of which the Company believes will have a material adverse effect on the Company’s business, financial condition or results of the operations.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following: Classification September 30, 2021 December 31, 2020 Cannabis: Raw materials $ 9,340 $ 13,168 Work-in-process 3,591 2,971 Finished goods 18,003 13,722 Packaging 5,205 2,360 Produce and Energy: Crop inventory 15,669 13,441 Purchased produce inventory 1,997 810 Spare parts inventory 129 127 Inventory $ 53,934 $ 46,599

Property Plant And Equipment (T

Property Plant And Equipment (Tables)	9 Months Ended
	Sep. 30, 2021
Property Plant And Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consisted of the following: Classification September 30, 2021 December 31, 2020 Land $ 13,922 $ 13,895 Leasehold and land improvements 5,118 4,154 Buildings 151,989 142,060 Machinery and equipment 77,568 69,390 Construction in progress 49,955 49,512 Less: Accumulated depreciation (102,281 ) (91,991 ) Property, plant and equipment, net $ 196,271 $ 187,020

Intangibles (Tables)

Intangibles (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Intangibles consisted of the following: Classification September 30, 2021 December 31, 2020 Licenses $ 12,824 $ 12,870 Branding 3,697 3,688 Computer Software 947 945 Other 144 — Less: Accumulated amortization (779 ) (192 ) Intangibles, net $ 16,833 $ 17,311
Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets	The expected future amortization expense for definite-lived intangible assets as of September 30, 2021 was as follows: Fiscal period Remainder of 2021 $ 197 2022 786 2023 780 2024 780 2025 688 Thereafter 9,761 Intangibles, net $ 12,992

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Summary of lease related expenses	The components of lease related expenses are as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Operating lease expense (a) $ 757 $ 533 $ 2,020 $ 1,649 Finance lease expense: Amortization of right-of-use assets $ 4 $ 12 $ 21 $ 51 Interest on lease liabilities — 1 1 3 Total finance lease expense $ 4 $ 13 $ 22 $ 54 (a) Includes short-term lease costs of $194 and $275 for the three months ended September 30, 2021 and 2020, respectively, and $497 and $315 for the nine months ended September 30, 2021 and 2020, respectively.
Schedule includes other information about leases	Cash paid for amounts included in the measurement of lease liabilities: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Operating cash flows from operating leases $ 122 $ 308 $ 376 $ 935 Operating cash flows from finance leases $ - $ 1 $ 1 $ 3 Finance cash flows from finance leases $ 227 $ 12 $ 537 $ 51 September 30, 2021 Weighted average remaining lease term: Operating leases 6.5 Finance leases 0.9 Weighted average discount rate: Operating leases 8.43% Finance leases 6.25%
Summary of maturities of lease liabilities	Maturities of lease liabilities are as follows: Operating leases Finance leases Remainder of 2021 $ 583 $ 5 2022 2,137 9 2023 1,900 — 2024 1,386 — 2025 1,145 — Thereafter 4,348 — Undiscounted lease cash flow commitments 11,499 14 Reconciling impact from discounting (3,411 ) (2 ) Lease liabilities on consolidated statement of financial position as of September 30, 2021 $ 8,088 $ 12

Pure Sunfarms Acquisitions (Tab

Pure Sunfarms Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2021
Pure Sunfarms [Member]
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 Summarized financial information of Pure Sunfarms: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales $ 27,393 $ 17,048 $ 69,614 $ 39,571 Cost of sales* (14,244 ) (11,154 ) (44,433 ) (23,678 ) Gross Margin 13,149 5,894 25,181 15,893 Selling, general and administrative expenses (5,510 ) (2,447 ) (15,131 ) (6,731 ) Income from operations 7,639 3,447 10,050 9,162 Interest expense, net (563 ) (386 ) (1,362 ) (734 ) Foreign exchange (loss) gain 105 (56 ) (131 ) (207 ) Loss on disposal — — (40 ) — Other income, net** 131 (131 ) (188 ) 4,202 Income before taxes 7,312 2,874 8,329 12,423 Provision for income taxes (2,024 ) (417 ) (2,654 ) (3,012 ) Net income $ 5,288 $ 2,457 $ 5,675 $ 9,411

Balanced Health Botanical Acqui

Balanced Health Botanical Acquisition (Tables) - Balanced Health Botanicals	9 Months Ended
	Sep. 30, 2021
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	The following table shows the preliminary allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 30,000 Village Farms common shares issued 4,707,113 $ 8.87 41,752 Working capital adjustment $ 192 Total fair value of consideration $ 71,944 August 16, 2021 ASSETS Cash and cash equivalents $ 4,056 Trade and other receivables, net 1,030 Inventories 1,796 Prepaid expenses and deposits 667 Property, plant and equipment 1,900 Right-of-use asset 5,099 Goodwill 69,269 Intangibles 144 Other assets 362 Total assets 84,323 LIABILITIES Trade payables 672 Accrued liabilities 5,974 Deferred revenue 192 Lease liability 5,541 Total liabilities 12,379 Net assets acquired 71,944
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information presents the Company’s consolidated results assuming the Balanced Health Acquisition occurred on January 1, 2020. Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales $ 75,872 $ 51,518 $ 214,060 $ 150,283 Net income $ 2,376 $ (134) $ (6,816) $ 250

Investment In Joint Ventures _2

Investment In Joint Ventures And Minority Interests (Tables) - Village Fields Hemp USA LLC [Member]	9 Months Ended
	Sep. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Summary of company share of the joint venture	The Company’s share of the joint venture consisted of the following: Balance, January 1, 2020 $ — Share of net loss (552 ) Losses applied against joint venture note receivable 552 Balance, December 31, 2020 $ — Balance, January 1, 2021 $ — Share of net loss (175 ) Losses applied against joint venture note receivable 175 Balance, September 30, 2021 $ —
Summary of summarized financial information	Summarized financial information of VF Hemp: September 30, 2021 December 31, 2020 Current assets Inventory $ 4,035 $ 4,035 Other current assets 189 302 Non-current assets 857 937 Current liabilities (1,529 ) (1,472 ) Non-current liabilities (13,715 ) (13,697 ) Net assets $ (10,163 ) $ (9,895 ) Reconciliation of net assets: Accumulated retained earnings $ (9,905 ) $ (3,791 ) Net loss (268 ) (6,114 ) Contributions from joint venture partners 10 10 Net assets $ (10,163 ) $ (9,895 )

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of Debt	September 30, 2021 December 31, 2020 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $164 and accrued interest at a rate of 3.691%; matures April 1, 2025 $ 27,214 $ 28,690 Term Loan - VFCE: CA$3.0M - non-revolving fixed rate loan with fixed interest rate of 4.98%; matures June 2023 595 797 Advance on term loan - VFCE: CA$250 - repayable in monthly installments of principle plus interest rate of CA$ prime rate plus 200 basis points - paid in full June 2021 — 69 Term Loan - Pure Sunfarms - CA$19.0M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount, interest rate of 4.95%; matures February, 2024 12,177 13,385 Term loan - Pure Sunfarms - CA$25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount starting June 30, 2021, interest rate of 4.95%; matures February 2024 18,169 16,535 BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75%, matures December 31, 2031 4,910 4,905 Unamortized deferred financing fees — (302 ) Total $ 63,065 $ 64,079
Schedule of maturities of long term debt	The aggregate annual maturities of long-term debt for the remainder of 2021 and thereafter are as follows: Remainder of 2021 $ 1,920 2022 7,884 2023 7,534 2024 26,052 2025 22,278 Thereafter 3,491 Total $ 69,159

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Summary of Net Sales by the Countries and Business	The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Sales Produce $ 41,035 $ 42,939 $ 121,441 $ 122,356 Cannabis - Canada 27,393 — 69,614 — Cannabis - United States 3,838 — 3,838 — Energy 176 98 319 366 $ 72,442 $ 43,037 $ 195,212 $ 122,722 Gross margin Produce $ 2,052 $ 5,828 $ (1,045 ) $ 10,494 Cannabis - Canada 13,149 — 25,181 — Cannabis - United States 2,607 — 2,607 — Energy (59 ) (209 ) (1,422 ) (581 ) $ 17,749 $ 5,619 $ 25,321 $ 9,913

Income (Loss) Per Share (Tables

Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Income Per Share [Abstract]
Summary of Basic and Diluted Net Income (Loss) per Common Share	Basic and diluted net income (loss) per common share is calculated as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Numerator: Net income (loss) $ 745 $ 520 $ (11,154 ) $ 4,591 Denominator: Weighted average number of common shares - basic 84,823 58,536 80,671 55,946 Effect of dilutive securities- share-based employee options and awards 2,087 1,904 — 1,832 Weighted average number of common shares - diluted 86,910 60,440 80,671 57,778 Antidilutive options and awards 999 865 389 865 Net income (loss) per ordinary share: Basic $ 0.01 $ 0.01 $ (0.14 ) $ 0.08 Diluted $ 0.01 $ 0.01 $ (0.14 ) $ 0.08

Shareholders' Equity and Shar_2

Shareholders' Equity and Share Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of fair value of stock option valuation assumptions	Stock option activity for the nine months ended September 30, 2021 was as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2021 3,067,322 C$ 6.91 6.82 $ 20,051 Granted 220,300 C$ 12.17 9.49 $ — Exercised (177,000 ) C$ 1.34 1.14 $ — Outstanding at September 30, 2021 3,110,622 C$ 7.60 6.36 $ 13,035 Exercisable at September 30, 2021 2,069,329 C$ 6.19 5.16 $ 11,305
Summary of non-vested performance-based restricted share units	Performance-based shares activity for the nine months ended September 30, 2021 was as follows: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Outstanding at January 1, 2021 869,000 C$ 7.51 Received (370,000 ) C$ 6.94 Outstanding at September 30, 2021 499,000 C$ 7.93 Exercisable at September 30, 2021 114,000 C$ 7.97

Nature of Operations - Addition

Nature of Operations - Additional Information (Detail)	Sep. 30, 2021
Village Fields Hemp USA LLC VF Hemp [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	65.00%

Inventories - Summary of Invent

Inventories - Summary of Inventory Current (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventory [Line Items]
Inventories	$ 53,934	$ 46,599
Raw Materials | Cannabis Business [Member]
Inventory [Line Items]
Inventories	9,340	13,168
Work-In-Process | Cannabis Business [Member]
Inventory [Line Items]
Inventories	3,591	2,971
Finished Goods | Cannabis Business [Member]
Inventory [Line Items]
Inventories	18,003	13,722
Packaging | Cannabis Business [Member]
Inventory [Line Items]
Inventories	5,205	2,360
Crop Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	15,669	13,441
Purchased Produce [Member] | Produce And Energy
Inventory [Line Items]
Inventories	1,997	810
Spare Parts Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	$ 129	$ 127

Property Plant And Equipment -

Property Plant And Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Less: Accumulated depreciation	$ (102,281)	$ (91,991)
Property, plant and equipment, net	196,271	187,020
Land [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	13,922	13,895
Leaseholds and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	5,118	4,154
Building [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	151,989	142,060
Machinery and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	77,568	69,390
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 49,955	$ 49,512

Intangibles - Schedule of Acqui

Intangibles - Schedule of Acquired Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]
Less: Accumulated amortization	$ (779)	$ (192)
Intangibles, net	16,833	17,311
Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	12,824	12,870
Branding [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	3,697	3,688
Computer Software [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	947	$ 945
Other [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	$ 144

Intangibles - Schedule of Expec

Intangibles - Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets (Detail) $ in Thousands	Sep. 30, 2021USD ($)
Fiscal period
Remainder of 2021	$ 197
2022	786
2023	780
2024	780
2025	688
Thereafter	9,761
Intangibles, net	$ 12,992

Leases - Summary Of Lease Relat

Leases - Summary Of Lease Related Expenses (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating lease expense	[1]	$ 757	$ 533	$ 2,020	$ 1,649
Amortization of right-of-use assets		4	12	21	51
Interest on lease liabilities			1	1	3
Total finance lease expense		$ 4	$ 13	$ 22	$ 54
[1]	Includes short-term lease costs of $194 and $275 for the three months ended September 30, 2021 and 2020, respectively, and $497 and $315 for the nine months ended September 30, 2021 and 2020, respectively.

Leases - Summary Of Lease Rel_2

Leases - Summary Of Lease Related Expenses (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Short-term lease costs	$ 194	$ 275	$ 497	$ 315

Leases - Schedule Includes Othe

Leases - Schedule Includes Other Information About Leases (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating cash flows from operating leases	$ 122	$ 308	$ 376	$ 935
Operating cash flows from finance leases		1	1	3
Finance cash flows from finance leases	$ 227	$ 12	$ 537	$ 51
Weighted average remaining lease term:
Operating leases	6 years 6 months		6 years 6 months
Finance leases	10 months 24 days		10 months 24 days
Weighted average discount rate:
Operating leases	8.43%		8.43%
Finance leases	6.25%		6.25%

Leases - Summary of maturities

Leases - Summary of maturities of lease matirities (Detail) $ in Thousands	Sep. 30, 2021USD ($)
Operating Leases [Member]
Remainder of 2021	$ 583
2022	2,137
2023	1,900
2024	1,386
2025	1,145
Thereafter	4,348
Undiscounted lease cash flow commitments	11,499
Reconciling impact from discounting	(3,411)
Lease liabilities on consolidated statement of financial position as of September 30, 2021	8,088
Finance Leases [Member]
Remainder of 2021	5
2022	9
Undiscounted lease cash flow commitments	14
Reconciling impact from discounting	(2)
Lease liabilities on consolidated statement of financial position as of September 30, 2021	$ 12

Business Combinations - Pure Su

Business Combinations - Pure Sunfarms Acquisition (Details) - Pure Sunfarms [Member] $ in Thousands, $ in Thousands	Nov. 02, 2020USD ($)shares	Nov. 02, 2020CAD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Nov. 02, 2020CAD ($)shares	Mar. 02, 2020USD ($)	Mar. 02, 2020CAD ($)
Business Acquisition [Line Items]
Promissory notes payable	$ 15,011
Goodwill	24,087
Gain on revaluation of previously held investment	$ 23,600
Additional equity transferred percent						2.50%	2.50%
Additional equity interest received fair value						$ 4,700
Canada, Dollars [Member]
Business Acquisition [Line Items]
Goodwill		$ 30,618
Additional equity interest received fair value							$ 6,500
Emerald Health [Member]
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Nov. 2, 2020	Nov. 2, 2020
Business acquisition, name of acquired entity	Emerald Health Therapeutics Inc. (“Emerald”)	Emerald Health Therapeutics Inc. (“Emerald”)
Business acquisition, percentage of voting interests acquired	100.00%				100.00%
Business combination, consideration transferred, total	$ 60,000
Payments to acquire businesses	45,000
Promissory notes payable	$ 15,000
Emerald Health [Member] | Joint Venture [Member]
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired	58.70%				58.70%
Equity (losses) earnings from unconsolidated entities			$ 1,443	$ 5,437
Emerald Health [Member] | Canada, Dollars [Member]
Business Acquisition [Line Items]
Business combination, consideration transferred, total		$ 79,900
Payments to acquire businesses		$ 60,000
Promissory notes payable					$ 19,900
Emerald Health [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Number of shares acquired | shares	36,958,500				36,958,500

Business Combinations - Summary

Business Combinations - Summary of Assets and Liabilites (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Nov. 02, 2020
ASSETS
Goodwill	$ 93,356	$ 24,027
Pure Sunfarms [Member]
Business Acquisition [Line Items]
Cash			$ 45,259
Promissory note			15,011
Shareholder loan			4,529
Promissory note owed to PSF from Emerald			439
Due to related party			61
Total fair value of consideration			158,180
ASSETS
Cash and cash equivalents			10,860
Trade receivables, net			10,553
Inventories			32,393
Prepaid expenses and deposits			3,572
Property, plant and equipment			122,831
Goodwill			23,095
Intangibles			16,670
Total assets			219,974
LIABILITIES
Trade payables			3,849
Accrued liabilities			13,062
Income taxes payable			2,173
Current maturities of long-term debt			2,306
Deferred revenue			77
Long-term debt			23,903
Deferred tax liabilities			16,424
Total liabilities			61,794
Net assets acquired			$ 158,180
Pure Sunfarms [Member] | Village Farms
Business Acquisition [Line Items]
Fair value of previously held investment shares held by Village Farms, shares			52,569,197
Business acquisition, share price			$ 1.767
Fair value of previously held investment shares held by Village Farms			$ 92,881

Business Combinations - Summa_2

Business Combinations - Summary of summarized financial information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Sales	$ 72,442	$ 43,037	$ 195,212	$ 122,722
Gross margin	17,749	5,619	25,321	9,913
Loss on disposal of assets			(40)	(6)
Net income (loss)	745	520	(11,154)	4,591
Pure Sunfarms [Member]
Business Acquisition [Line Items]
Sales	27,393	17,048	69,614	39,571
Cost of sales*	(14,244)	(11,154)	(44,433)	(23,678)
Gross margin	13,149	5,894	25,181	15,893
Selling, general and administrative expenses	(5,510)	(2,447)	(15,131)	(6,731)
Income from operations	7,639	3,447	10,050	9,162
Interest expense, net	(563)	(386)	(1,362)	(734)
Foreign exchange (loss) gain	105	(56)	(131)	(207)
Loss on disposal of assets			(40)
Other income, net**	131	(131)	(188)	4,202
Income before taxes	7,312	2,874	8,329	12,423
Provision for income taxes	2,024	417	2,654	3,012
Net income (loss)	$ 5,288	$ 2,457	$ 5,675	$ 9,411

Business Combinations - Summa_3

Business Combinations - Summary of summarized financial information (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Combinations [Abstract]
Depreciation Expense	$ 1,353	$ 961	$ 3,944	$ 1,973
Gain recognized on settlement of net liabilities	$ 4,348			$ 4,348

Business Combinations - Balance

Business Combinations - Balanced Health Botanicals Acquisition - Additional Information (Details) - USD ($) $ in Thousands	Aug. 16, 2021	Sep. 30, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill		$ 93,356	$ 24,027
Balanced Health Botanicals
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Aug. 16, 2021
Business acquisition, percentage of voting interests acquired	100.00%
Payments to acquire businesses	$ 30,000
Business acquisition, purchase price consideration number of shares issued	4,707,113
Business combination, consideration transferred, total	$ 42,000
Percentage of common shares cease to be restricted shares on closing date	0.25%
Percentage of common shares cease to be restricted shares on last day of 4 month period	0.25%
Percentage of common stock cease to be restricted shares on last day of 8 month period	0.25%
Percentage of common stock cease to be restricted shares on last day of 12 month period	0.25%
Goodwill	$ 69,269
Balanced Health Botanicals | Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition, purchase price consideration number of shares issued	4,707,113

Business Combinations - Balan_2

Business Combinations - Balanced Health Botanicals Acquisition - Summary of Assets and Liabilities (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2021	Aug. 16, 2021	Dec. 31, 2020
ASSETS
Goodwill	$ 93,356		$ 24,027
Balanced Health Botanicals
Business Acquisition [Line Items]
Cash		$ 30,000
Village Farms common shares issued		4,707,113
Business acquisition, share price		$ 8.87
Village Farms common shares issued		$ 41,752
Working capital adjustment		192
Total fair value of consideration		71,944
ASSETS
Cash and cash equivalents		4,056
Trade receivables, net		1,030
Inventories		1,796
Prepaid expenses and deposits		667
Property, plant and equipment		1,900
Right-of-use asset		5,099
Goodwill		69,269
Intangibles		144
Other assets		362
Total assets		84,323
LIABILITIES
Trade payables		672
Accrued liabilities		5,974
Deferred revenue		192
Lease liability		5,541
Total liabilities		12,379
Net assets acquired		$ 71,944

Business Combinations - Balan_3

Business Combinations - Balanced Health Botanicals Acquisition - Summary of Unaudited Pro Forma Financials (Details) - Balanced Health Botanicals - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Sales	$ 75,872	$ 51,518	$ 214,060	$ 150,283
Net income	$ 2,376	$ (134)	$ (6,816)	$ 250

Investment In Joint Ventures _3

Investment In Joint Ventures And Minority Interests - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2021EUR (€)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021EUR (€)	Dec. 31, 2020USD ($)
Receivable from Joint Venture | $		$ 3,385		$ 3,385			$ 3,545
Leli Holland B V | Option Agreement
Right to acquire ownership interest percentage	80.00%
Payment to acquire ownership interest | €	€ 50,000
Transaction value to acquire interest | €	€ 3,950,000
Due to related party | €						€ 950,000
Number of years option is exercisable at sole discretion	5 years
Altum International Pty Ltd
Equity ownership percentage		11.90%		11.90%		11.90%
V F Hemp
Equity income (losses) from joint venture | $		$ 38	$ (137)	$ (175)	$ (552)
Receivable from Joint Venture | $		$ 3,385		$ 3,385

Investment In Joint Ventures _4

Investment In Joint Ventures And Minority Interests - Summary of company share of the joint venture (Detail) - Village Fields Hemp USA LLC [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Share of net loss	$ (175)	$ (552)
Losses applied against joint venture note receivable	$ 175	$ 552

Investment In Joint Ventures _5

Investment In Joint Ventures And Minority Interests - Summary of summarized financial information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Current liabilities
Current liabilities	$ 59,022		$ 59,022		$ 72,280
Summary of Income Statement:
Net income (loss)	745	$ 520	(11,154)	$ 4,591
Village Fields Hemp USA LLC [Member]
Current assets
Inventory	4,035		4,035		4,035
Other current assets	189		189		302
Current liabilities
Non-current liabilities	(13,715)		(13,715)		(13,697)
Net assets	(10,163)		(10,163)		(9,895)
Reconciliation of net assets:
Accumulated retained earnings	(9,905)		(9,905)		(3,791)
Contributions from joint venture partners	10		10		10
Net assets	(10,163)		(10,163)		(9,895)
Summary of Income Statement:
Net income (loss)			(268)		(6,114)
Village Fields Hemp USA LLC [Member] | Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Current assets
Non-current assets	857		857		937
Current liabilities
Current liabilities	$ (1,529)		$ (1,529)		$ (1,472)

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Term Loan	$ 63,065	$ 64,079
Unamortized deferred financing fees		(302)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Term Loan	27,214	28,690
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Term Loan	595	797
Advance On Term Loan VFCE [Member]
Debt Instrument [Line Items]
Term Loan		69
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	12,177	13,385
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	18,169	16,535
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	$ 4,910	$ 4,905

Debt - Schedule of Debt (Parent

Debt - Schedule of Debt (Parenthetical) (Detail) - 9 months ended Sep. 30, 2021 $ in Millions, $ in Millions	USD ($)	CAD ($)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment	$ 164
Debt instrument, interest rate during period	3.691%	3.691%
Debt Instrument Maturity Date	Apr. 1, 2025	Apr. 1, 2025
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 3
Debt instrument, interest rate during period	4.98%	4.98%
Debt Instrument Maturity Date	Jun. 30, 2023	Jun. 30, 2023
Advance On Term Loan VFCE [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 250
Debt instrument, basis point	200	200
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 19
Debt instrument, interest rate during period	4.95%	4.95%
Debt Instrument Maturity Date	Feb. 29, 2024	Feb. 29, 2024
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 25
Debt instrument, interest rate during period	4.95%	4.95%
Debt Instrument Maturity Date	Feb. 29, 2024	Feb. 29, 2024
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Debt instrument, maturity start date	Jun. 30, 2021	Jun. 30, 2021
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate during period	3.75%	3.75%
Debt Instrument Maturity Date	Dec. 31, 2031	Dec. 31, 2031

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Disclosure Of Borrowings [Line Items]
Line of credit		$ 2,000,000
Weighted average interest rate	5.30%	5.11%
Accounts Payable and Accrued Liabilities
Disclosure Of Borrowings [Line Items]
Accrued interest payable	$ 34,000	$ 189,000
Non-Revolving Variable Rate Term Loan 2021 [Member] | FCC Loan [Member]
Disclosure Of Borrowings [Line Items]
Securities pledged as collateral	223,788,000	86,664,000
Revolving Operating Loan [Member]
Disclosure Of Borrowings [Line Items]
Amounts drawn on facility	0	2,000,000
Securities pledged as collateral	28,414,000	23,443,000
Term Loan One [Member]
Disclosure Of Borrowings [Line Items]
Line of credit	$ 0	$ 0

Debt - Summary of Aggregate Ann

Debt - Summary of Aggregate Annual Maturities of Long-Term Debt (Detail) $ in Thousands	Sep. 30, 2021USD ($)
Debt Disclosure [Abstract]
Remainder of 2021	$ 1,920
2022	7,884
2023	7,534
2024	26,052
2025	22,278
Thereafter	3,491
Long-term debt	$ 69,159

Related Party Transactions An_2

Related Party Transactions And Balances - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Salary and benefits to employee	$ 96	$ 84
Outstanding loan balance repaid by employee	124
Employee Relocation [Member]
Related Party Transaction [Line Items]
Relocation expense			$ 249
Grid Loan Agreement [Member]
Related Party Transaction [Line Items]
Loans receivable, related parties	$ 3,385		$ 3,545
V F Hemp
Related Party Transaction [Line Items]
Debt securities maturity date	Mar. 25, 2022
Loan interest rate percentage	8.00%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Estimated Average Annual Tax Rate			22.00%	24.00%
(Recovery) provision of income taxes	$ 1,077	$ 336	$ (2,543)	$ (607)

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2021Segment
Segment Reporting [Abstract]
Number of operating segments	4

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of net sales by the countries and business (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues [Abstract]
Revenues	$ 72,442	$ 43,037	$ 195,212	$ 122,722
Gross Profit [Abstract]
Gross Margin	17,749	5,619	25,321	9,913
Produce Business [Member]
Revenues [Abstract]
Revenues	41,035	42,939	121,441	122,356
Gross Profit [Abstract]
Gross Margin	2,052	5,828	(1,045)	10,494
Cannabis Canada Business [Member]
Revenues [Abstract]
Revenues	27,393		69,614
Gross Profit [Abstract]
Gross Margin	13,149		25,181
Cannabis Unites States Business [Member]
Revenues [Abstract]
Revenues	3,838		3,838
Gross Profit [Abstract]
Gross Margin	2,607		2,607
Energy Business [Member]
Revenues [Abstract]
Revenues	176	98	319	366
Gross Profit [Abstract]
Gross Margin	$ (59)	$ (209)	$ (1,422)	$ (581)

Income (Loss) Per Share - Summa

Income (Loss) Per Share - Summary of Basic and Diluted Net Income (Loss) per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator:
Net income (loss)	$ 745	$ 520	$ (11,154)	$ 4,591
Denominator:
Weighted average number of common shares - basic	84,823	58,536	80,671	55,946
Effect of dilutive securities- share-based employee options and awards	2,087	1,904		1,832
Weighted average number of common shares - diluted	86,910	60,440	80,671	57,778
Antidilutive options and awards	999	865	389	865
Net income (loss) per ordinary share:
Basic	$ 0.01	$ 0.01	$ (0.14)	$ 0.08
Diluted	$ 0.01	$ 0.01	$ (0.14)	$ 0.08

Shareholders' Equity and Shar_3

Shareholders' Equity and Share Based Compensation - Additional Information (Detail) $ / shares in Units, $ in Thousands	Jan. 20, 2021USD ($)$ / sharesshares	Sep. 10, 2020$ / sharesshares	Sep. 30, 2021USD ($)shares	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)shares	Sep. 30, 2020USD ($)	Aug. 16, 2021shares	Dec. 31, 2020shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Common Stock, Shares, Issued			86,241,701		86,241,701		4,707,113	66,911,811
Commencing date					May 26, 2021
Terminating date					May 25, 2022
Purchase of common shares			4,062,309		4,062,309
Common shares purchase percentage					0.05
Stock repurchased during period, shares					536,052
Stock repurchased cost | $			$ 1,020		$ 5,000
Shares issued in pubic offering, net of issuance costs (in shares)	10,887,097	9,396,226
Purchase price | $ / shares	$ 12.40
Proceeds from issuance of common stock before placement agent fees and offering expense | $	$ 135,000
Description of units sold		Each unit that was sold consisted of one common share of the Company and one-half (0.5) of a warrant to purchase a common share of the Company
Class of warrant or right, exercise price of warrants or rights | $ / shares		$ 5.80
Warrants exercisable beginning date		Mar. 10, 2021
Warrants exercisable expiration date		Sep. 10, 2025
Number of warrants exercised			3,188,680		3,188,680
Share based compensation expense | $			$ 1,820	$ 472	$ 5,705	$ 1,329

Shareholders' Equity and Shar_4

Shareholders' Equity and Share Based Compensation - Summary Of Stock Option (Detail) - Stock Option [Member] $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Sep. 30, 2021$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Beginning balance | shares	3,067,322
Number of Options, Granted | shares	220,300
Number of Options, Exercised | shares	(177,000)
Number of Options, Ending balance | shares	3,110,622	3,067,322
Number of Options, Exercisable | shares	2,069,329
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 6.91
Weighted Average Exercise Price, Granted | $ / shares	12.17
Weighted Average Exercise Price, Exercised | $ / shares	1.34
Weighted Average Exercise Price, Ending balance | $ / shares	$ 7.60	$ 6.91
Weighted Average Exercise Price, Exercisable | $ / shares			$ 6.19
Weighted Average Remaining Contractual Term (years)	6 years 4 months 9 days	6 years 9 months 25 days
Weighted Average Remaining Contractual Term (years), Granted	9 years 5 months 26 days
Weighted Average Remaining Contractual Term (years), Exercised	1 year 1 month 20 days
Weighted Average Remaining Contractual Term (years), Exercisable	5 years 1 month 28 days
Aggregate Intrinsic Value, Ending balance | $	$ 13,035	$ 20,051
Aggregate Intrinsic Value, Excercisable | $	$ 11,305

Shareholders' Equity and Shar_5

Shareholders' Equity and Share Based Compensation - Summary of Performance base restricted share unit activity (Detail) - Performance-Based Restricted Share Unit [Member]	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance | shares	869,000
Number of Performance-based Restricted Share Units, Received | shares	(370,000)
Number of Performance-based Restricted Share Units, Ending balance | shares	499,000
Number of Performance-based Restricted Share Units, Exercisable | shares	114,000
Weighted Average Grant Date Fair Value, Beginning balance | $ / shares	$ 7.51
Weighted Average Grant Date Fair Value, Received | $ / shares	6.94
Weighted Average Grant Date Fair Value, Ending balance | $ / shares	7.93
Weighted Average Grant Date Fair Value, Exercisable | $ / shares	$ 7.97